Budapest, Hungary

Antal Feller


Average Co-Inventor Count = 12.3

ph-index = 1

Forward Citations = 5(Granted Patents)


Company Filing History:


Years Active: 1987-1993

Loading Chart...
2 patents (USPTO):Explore Patents

Title: Antal Feller: Innovator in Pharmaceutical Chemistry

Introduction

Antal Feller is a notable inventor based in Budapest, Hungary. He has made significant contributions to the field of pharmaceutical chemistry, particularly through his innovative work on thiazolidine derivatives. With a total of 2 patents, Feller's inventions are aimed at improving treatments for various diseases.

Latest Patents

Feller's latest patents include the development of new 2-(substituted imino)-thiazolidines and a process for their preparation. This invention relates to pharmaceutical compositions that utilize these compounds for the treatment of diseases. The new 2-(substituted imino)-thiazolidine derivatives correspond to a specific general formula, wherein R¹ and R² can represent various substituents such as halogen, nitro, C₁-₄ alkoxy, or C₁-₄ alkyl, which may also carry additional halogen substituents. Additionally, he has developed novel iminothiazolidine derivatives, which also follow a defined formula, showcasing his expertise in creating effective pharmaceutical compounds.

Career Highlights

Antal Feller is associated with Egis Gyogyszergyar, a prominent pharmaceutical company in Hungary. His work at this institution has allowed him to focus on innovative drug development, contributing to advancements in medical treatments.

Collaborations

Feller has collaborated with notable colleagues such as Karoly Lempert and Gyula Hornyak. These partnerships have likely enhanced his research and development efforts, leading to successful innovations in the pharmaceutical field.

Conclusion

Antal Feller's contributions to pharmaceutical chemistry through his patents and collaborations highlight his role as an influential inventor. His work continues to impact the treatment of diseases, showcasing the importance of innovation in healthcare.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…